A Simple Key For ABBV-744 BRD4 inhibition in cancer cell lines Unveiled
The current work examined the potential of using ARV-825 and ABBV-744 to enhance the effectiveness of tamoxifen or fulvestrant additionally palbociclib. ARV-825 was effective in both of those p53 wild-sort (WT) breast tumor cells and in cells lacking practical p53 both by yourself or in combination with tamoxifen, while the effectiveness of ABBV-74